Effect of Cryolipolysis on Inflammatory Factors in Obese Postmenopausal Women
1 other identifier
interventional
46
1 country
1
Brief Summary
This study was conducted to investigate the effect of Cryolipolysis on inflammatory factors in obese postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Jan 2025
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedFirst Submitted
Initial submission to the registry
June 24, 2026
CompletedFirst Posted
Study publicly available on registry
June 30, 2026
CompletedJune 30, 2026
June 1, 2026
7 months
June 24, 2026
June 24, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Serum interleukin-6
Serum interleukin-6 (IL-6) levels were measured from venous blood samples using an enzyme-linked immunosorbent assay (ELISA). IL-6 concentrations were expressed in picograms per milliliter (pg/mL). The normal serum IL-6 level in healthy adults is generally less than 7 pg/mL, higher level indicates inflammatory conditions.
12 weeks
C- Reactive Proteins
Serum C-reactive protein (CRP) levels were measured from venous blood samples using an immunoturbidimetric assay. CRP concentrations were expressed in milligrams per liter (mg/L). A CRP value below 5 mg/L is generally considered within the normal range. Higher levels indicate inflammatory diseases.
12 weeks
Secondary Outcomes (9)
Body weight
12 weeks
Body mass index
12 weeks
waist circumference
12 weeks
Hip circumference
12 weeks
waist-hip ratio
12 weeks
- +4 more secondary outcomes
Study Arms (2)
Cryolipolysis and aerobic exercise group
EXPERIMENTALThe participants received cryolipolysis sessions on abdominal region (30 minutes/2 sessions per week for 12 weeks) in addition to moderate intensity Aerobic exercises on treadmill for 30 minutes/ 2sessions per week for 12 weeks.
aerobic exercise group
ACTIVE COMPARATORThe participants received aerobic exercises on treadmill only for 30 minutes/ 2sessions per week for 12 weeks.
Interventions
Vacuum controllable head with cold temperature range from -10 to 5°C technique was adjusted according to each patient tolerance, after careful patient sensation examination and vital signs evaluation before and after each session. Cryolipolysis sessions was applied at the hypogastrium area, 5 cm below the umbilicus, for 30 minutes with temperature degree of -5°C using an anti- freezing membrane to avoid cold burn. After starting the device on, the patient was instructed with safety measures to pull the key off if there was any intolerable abnormal sensation.
Participants received moderate intensity aerobic exercises 2 times/week for 12 weeks by using treadmill. Each session took about 30 minutes as the following: 5 minutes warming up exercises by walking on the treadmill by low speed, 20 minutes walking at moderate intensity (70% of the maximal heart rate) and 5 minutes are cooling down by walking on the treadmill with low speed as in warming up (2 sessions/week)
Eligibility Criteria
You may qualify if:
- All participants were postmenopausal women.
- Their ages were ranged from 50 to 60 years old.
- Body mass index was ranged from 30-40 kg/m2.
- Waist to hip Ratio was between 0.8-1.0.
You may not qualify if:
- Systematic disease (uncontrolled hypertension, diabetes mellitus).
- Thyroid, liver and kidney dysfunctions.
- Psychiatric disorders.
- Women received any hormonal therapy or received corticosteroids in the last six months prior to the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Nada ElSayed Mohamed
Cairo, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Samira Swdky, Professor
Al-Azhar University
- STUDY CHAIR
Abeer ElDeeb, Professor
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
June 24, 2026
First Posted
June 30, 2026
Study Start
January 1, 2025
Primary Completion
July 15, 2025
Study Completion
July 30, 2025
Last Updated
June 30, 2026
Record last verified: 2026-06